jp
en
News
Technology
Company
Contact
jp
en
Contact
News
2025.02.18
General
Neusignal Therapeutics Provides Alzheimer’s Disease Treatment Candidate (NTX-083) for Investigator-Initiated Clinical Trial in Healthy Adults at the University of Tokyo Hospital
2025.01.31
IR
Neusignal Therapeutics Raises ¥2.25 Billion in Series A Funding– Plans To Begin Clinical Trials and Strengthen Development Infrastructure for U.S. Expansion
Posts navigation
Prev
1
2
